• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼眶磁共振成像结合临床活动评分可提高Graves 眼病疾病活动度检测和免疫抑制治疗反应预测的敏感性。

Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy.

机构信息

Department of Endoclinology, Noguchi Thyroid Clinic and Hospital Foundation, Oita, Japan.

出版信息

Endocr J. 2010;57(10):853-61. doi: 10.1507/endocrj.k10e-156. Epub 2010 Aug 19.

DOI:10.1507/endocrj.k10e-156
PMID:20733265
Abstract

The aim of this study was to demonstrate that the addition of orbital magnetic resonance (MR) imaging can provide improvement in sensitivity of detection of active disease and the prediction of the response to intravenous glucocorticoid therapy (ivGC), over clinical activity score (CAS) alone. A prospective case series was studied at our institution. Forty eight patients were examined by CAS and orbital MR imaging. The maximum of T2 relaxation times of extraocular muscles (maxT2RT) and other parameters were evaluated by MR imaging. Thirty five of 48 patients underwent ivGC. Twenty of 35 patients, whose CAS was 2 points or less, were evaluated for the response to ivGC. The correlation between CAS and maxT2RT was evaluated. Differentiation of active and inactive GO was performed by CAS and orbital MR imaging. The response to ivGC was evaluated by CAS, orbital MR imaging and ophthalmic parameters. As a result, CAS and maxT2RT showed significant positive correlation (r=0.58, p<0.0001), and 15 patients were positive by CAS and orbital MR imaging. However, 20 patients were positive by only MR imaging. In those 20 patients, there was significant improvement after ivGC. We concluded that orbital MR imaging combined with CAS could improve the sensitivity of detection of active disease and the prediction of the response to ivGC. In addition, even if only one parameter of CAS is positive, further examination with orbital MR imaging is advised.

摘要

本研究旨在证明,与单纯临床活动评分(CAS)相比,眼眶磁共振成像(MR)的加入可以提高对活动性疾病的检测敏感性和预测静脉内糖皮质激素治疗(ivGC)反应的能力。本研究在我们机构进行了前瞻性病例系列研究。48 例患者接受了 CAS 和眼眶 MR 成像检查。通过 MR 成像评估了眼外肌(maxT2RT)最大 T2 弛豫时间和其他参数的最大值。35 例 48 例患者接受了 ivGC。20 例 CAS 为 2 分或更低的患者,对 ivGC 反应进行了评估。评估了 CAS 和 maxT2RT 之间的相关性。通过 CAS 和眼眶 MR 成像对活动性和非活动性 GO 进行了区分。通过 CAS、眼眶 MR 成像和眼科参数评估了 ivGC 的反应。结果,CAS 和 maxT2RT 显示出显著的正相关(r=0.58,p<0.0001),15 例患者的 CAS 和眼眶 MR 成像均为阳性。然而,20 例患者仅通过 MR 成像呈阳性。在这 20 例患者中,ivGC 后有显著改善。我们得出结论,眼眶 MR 成像与 CAS 相结合可以提高对活动性疾病的检测敏感性和预测 ivGC 反应的能力。此外,即使 CAS 的一个参数为阳性,也建议进一步进行眼眶 MR 成像检查。

相似文献

1
Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy.眼眶磁共振成像结合临床活动评分可提高Graves 眼病疾病活动度检测和免疫抑制治疗反应预测的敏感性。
Endocr J. 2010;57(10):853-61. doi: 10.1507/endocrj.k10e-156. Epub 2010 Aug 19.
2
Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.三维眼眶磁共振T2成像在格雷夫斯眼病患者评估中的应用
J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):938-942. doi: 10.1007/s11596-017-1831-8. Epub 2017 Dec 21.
3
The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor.静脉注射类固醇治疗活动期格雷夫斯眼病的治疗效果受反应时间影响,但不受糖皮质激素受体多态性影响。
Eur J Endocrinol. 2013 Nov 22;170(1):55-61. doi: 10.1530/EJE-13-0611. Print 2014 Jan.
4
VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY.未经眼眶放射治疗的 Graves 眼病患者接受大剂量静脉糖皮质激素冲击治疗后,影响其长期转归的因素。
Endocr Pract. 2016 Oct;22(10):1177-1186. doi: 10.4158/E161376.OR.
5
Meta-analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy.甲泼尼龙冲击疗法治疗Graves眼病的荟萃分析。
Clin Exp Ophthalmol. 2014 Nov;42(8):769-77. doi: 10.1111/ceo.12317. Epub 2014 Apr 4.
6
Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial.两种不同静脉注射甲泼尼龙方案治疗中重度活动性格雷夫斯眼病患者的比较:一项前瞻性随机对照试验。
Endocr J. 2017 Feb 27;64(2):141-149. doi: 10.1507/endocrj.EJ16-0083. Epub 2016 Nov 16.
7
Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy.接受皮质类固醇治疗的格雷夫斯眼病患者眼部自身免疫某些标志物的纵向行为与眼部检查结果变化之间的关系。
Clin Endocrinol (Oxf). 2003 Sep;59(3):388-95. doi: 10.1046/j.1365-2265.2003.01861.x.
8
Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score.格雷夫斯眼病的疾病活动度:眼眶磁共振成像诊断及其与临床评分的相关性
Neuroradiol J. 2013 Oct;26(5):555-64. doi: 10.1177/197140091302600509. Epub 2013 Nov 7.
9
Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.与单独使用全身性激素相比,联合眼眶照射与全身性激素治疗中重度格雷夫斯眼病的初步研究。
Hong Kong Med J. 2005 Oct;11(5):322-30.
10
A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy.一项关于中重度活动性甲状腺相关性眼病静脉注射糖皮质激素治疗效果相关因素的单中心回顾性研究。
BMC Endocr Disord. 2018 Feb 20;18(1):13. doi: 10.1186/s12902-018-0240-8.

引用本文的文献

1
Effectiveness of intravenous glucocorticoids in active thyroid eye disease patients with low clinical activity scores.静脉注射糖皮质激素对临床活动评分低的活动性甲状腺眼病患者的疗效。
Endocrine. 2025 Jul 24. doi: 10.1007/s12020-025-04367-9.
2
Application progress of magnetic resonance imaging in thyroid associated ophthalmopathy.磁共振成像在甲状腺相关性眼病中的应用进展
Front Endocrinol (Lausanne). 2025 Jun 26;16:1537957. doi: 10.3389/fendo.2025.1537957. eCollection 2025.
3
The Value of MRI and Radiomics for the Diagnostic Evaluation of Thyroid-Associated Ophthalmopathy.
MRI及影像组学在甲状腺相关性眼病诊断评估中的价值
Diagnostics (Basel). 2025 Feb 6;15(3):388. doi: 10.3390/diagnostics15030388.
4
The diagnostic performance comparison between T2 mapping and Dixon against the activity of thyroid-associated ophthalmopathy: a systematic review and meta-analysis.T2 映射与 Dixon 成像在甲状腺相关眼病活动度诊断效能上的比较:一项系统评价与荟萃分析
Front Endocrinol (Lausanne). 2024 Dec 12;15:1502296. doi: 10.3389/fendo.2024.1502296. eCollection 2024.
5
Monocyte to high-density lipoprotein cholesterol ratio as a predictor of the activity of thyroid-associated ophthalmopathy.单核细胞与高密度脂蛋白胆固醇比值作为甲状腺相关性眼病活动度的预测指标。
Int J Ophthalmol. 2024 Dec 18;17(12):2276-2281. doi: 10.18240/ijo.2024.12.16. eCollection 2024.
6
Evaluation of fibroinflammatory activity in thyroid eye disease using [F]AlF-NOTA-FAPI-04 PET/CT: A prospective study.使用[F]AlF-NOTA-FAPI-04 PET/CT评估甲状腺眼病中的纤维炎症活性:一项前瞻性研究。
Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1890-1900. doi: 10.1007/s00259-024-07015-y. Epub 2024 Dec 13.
7
Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves' disease.格雷夫斯病产后甲状腺眼病诊断发生率与甲状腺功能的关系
Endocr J. 2025 Jan 6;72(1):103-113. doi: 10.1507/endocrj.EJ24-0401. Epub 2024 Oct 23.
8
Whole-orbit-based multiparametric assessment of disease activity of thyroid eye disease on Dixon MRI.基于全眼眶的多参数评估狄克逊 MRI 甲状腺眼病的疾病活动度。
Int Ophthalmol. 2024 May 3;44(1):213. doi: 10.1007/s10792-024-03138-1.
9
The Role of Thermal Camera in the Assessment of Thyroid Eye Disease Activity.热成像相机在甲状腺眼病活动度评估中的作用
Acta Inform Med. 2023;31(4):260-264. doi: 10.5455/aim.2023.31.260-264.
10
The evaluation of retrobulbar fat tissue in Graves' orbitopathy with shear-wave ultrasound elastography.应用剪切波超声弹性成像评估格雷夫斯眼病的球后脂肪组织。
Int Ophthalmol. 2024 Feb 6;44(1):13. doi: 10.1007/s10792-024-02962-9.